Domov › Rak dojke › Michigan › Ann Arbor
Klinične študije za Rak dojke v Ann Arbor, MI
27 študij za Rak dojke išče udeležence na lokacijah v Ann Arbor in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Vključevanje udeležencevFaza 3
- University of Michigan, Ann Arbor
A Study of PHST001 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- University of Michigan Rogel Cancer Center, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi stran
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- in še 4
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Vključevanje udeležencevFaza 1/2
- University of Michigan, Ann Arbor
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- University of Michigan, Ann Arbor
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Vključevanje udeležencevFaza 3
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Vključevanje udeležencevOpazovalna študija
- Trinity Health, Ann Arbor
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi stran
- in še 6
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- University of Michigan Rogel Cancer Center, Ann Arbor
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Vključevanje udeležencevFaza 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Vključevanje udeležencevFaza 1
- University of Michigan, Ann Arbor
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Vključevanje udeležencevFaza 4
- University of Michigan Rogel Cancer Center, Ann Arbor
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
Vključevanje udeležencevFaza 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
- in še 5
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Vključevanje udeležencevFaza 1/2
- Trinity Health, Ypsilanti · 7 mi stran
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
Vključevanje udeležencev
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Vključevanje udeležencev
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
Vključevanje udeležencevFaza 3
- University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Vključevanje udeležencevFaza 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi stran
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Michigan, Ann Arbor
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Vključevanje udeležencevFaza 1
- University of Michigan, Ann Arbor
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Vključevanje udeležencevOpazovalna študija
- Trinity Health-Michigan, Ypsilanti · 7 mi stran
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Ann Arbor
- Rak prostate27 študij
- Nemalicelični pljučni rak26 študij
- Rak (vse vrste)25 študij
- Rak pljuč23 študij
- Kolorektalni rak23 študij
- Srčno popuščanje22 študij
- Akutna mieločna levkemija17 študij
- Srčno-žilne bolezni16 študij
- Rak trebušne slinavke14 študij
- Melanom12 študij
- Možganska kap12 študij
- Ploščatocelični karcinom glave in vratu12 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.